Oral Trofosfamide in Elderly and/or Heavily Pretreated Patients with Metastatic Lung Cancer

Publisher： Karger

E-ISSN： 2296-5262|23|4|341-344

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.4, 2000-09, pp. : 341-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose Escalation Study for Defining the Maximum Tolerated Dose of Continuous Oral Trofosfamide in Pretreated Patients with Metastatic Lung Cancer

By  

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 534-538

Karger

Access to resources Recommend Favorite

A Retrospective Analysis of the Activity and Safety of Oral Etoposide in Heavily Pretreated Metastatic Breast Cancer Patients

By  

THE BREAST JOURNAL, Vol. 21, Iss. 3, 2015-05 ,pp. : 241-245

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor Growth Control by Oral Trofosfamide in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 1, 1998-03 ,pp. : 52-56

Karger

Access to resources Recommend Favorite

Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 93, Iss. 3, 2017-05 ,pp. : 191-196

Karger

Access to resources Recommend Favorite

Treatment Options in Anthracycline and/or Taxane Pretreated Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 476-478

Karger

Access to resources Recommend Favorite